PRESS RELEASE published on 10/09/2025 at 17:45, 1 year ago VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms its roadmap Valbiotis publishes its interim financial statements, confirms roadmap with successful commercialization, cash position of €13.2M, and growth drivers for 2026. Increased engagement with partners and all financial ambitions through 2030 affirmed Cash Position Valbiotis Commercialization Interim Financial Statements Growth Drivers
PRESS RELEASE published on 10/09/2025 at 17:45, 1 year ago VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms its roadmap Valbiotis publishes interim financial results with robust commercialization timeline, solid cash position and growth drivers activated, while confirming financial ambitions through 2030. International engagements with partners intensify Financial Results Cash Position Valbiotis Growth Drivers Commercialization Timeline
PRESS RELEASE published on 10/09/2025 at 17:45, 1 year ago Bellevue Group sells adbodmer AG through a management buy-out – business model sharpened Bellevue Group sells adbodmer AG to management in a buy-out, sharpening business model. Focus on healthcare strategy enhanced through the transaction Bellevue Group Healthcare Strategy Business Model Management Buy-Out Adbodmer AG
REGULATED PRESS RELEASE published on 10/09/2025 at 17:45, 1 year ago September 2025 ALTEN SA discloses total number of shares and voting rights as per legal requirements, listed on Euronext Paris. Company specializes in Engineering and IT services Euronext Paris Voting Rights ALTEN SA Engineering IT Services
PRESS RELEASE published on 10/09/2025 at 17:30, 1 year ago Biotest’s Yimmugo® launches in the United States Biotest AG launches Yimmugo®, a polyvalent human normal immunoglobulin (IVIg) for primary immunodeficiencies in the U.S., marking a significant milestone for the company's global growth strategy Biotest AG Yimmugo U.S. Launch Primary Immunodeficiencies IVIg
PRESS RELEASE published on 10/09/2025 at 17:00, 1 year ago Amrize Announces Date for Third Quarter 2025 Financial Results Amrize Ltd to announce third quarter 2025 financial results on October 28, 2025, followed by live webcast on October 29, 2025. Details at www.amrize.com/investors Financial Results Investors Webcast Third Quarter Amrize Ltd
PRESS RELEASE published on 10/09/2025 at 16:45, 1 year ago Invitation to Multitude AG’s 9M Earnings Call and Capital Markets Day 2025 – Join us virtually on 13 November 2025 at 13:00 CET Invitation to Multitude AG’s 9M Earnings Call and Capital Markets Day 2025. Join virtually on 13 November 2025 at 13:00 CET for financial updates and strategic insights Fintech Capital Markets Day Virtual Webcast Multitude AG 9M Earnings Call
PRESS RELEASE published on 10/09/2025 at 16:30, 1 year ago Rolling Stone Magazine Makes SMX a Headliner, Declaring its "PROOF is the New Flex" (NASDAQ:SMX) SMX is pioneering a new 'proof economy' with molecular marking technology for verifying sustainable materials, driving a market revolution with the Plastic Cycle Token Sustainable Materials SMX Plastic Cycle Token Molecular Marking Technology Proof Economy
PRESS RELEASE published on 10/09/2025 at 15:55, 1 year ago SMX Scores the Big Three - Cultural Validation from Rolling Stone, Compliance Leadership, and Proof as Currency (NASDAQ: SMX) SMX introduces molecular proof to establish trust in recycling, fire safety, and plastics, creating functioning markets based on verifiable standards Sustainability Recycling Fire Safety Plastics Markets SMX
PRESS RELEASE published on 10/09/2025 at 15:45, 1 year ago allnex to launch its European Defense Materials Program allnex launches European Defense Materials Program to boost innovation and support Europe's defense autonomy. Focus on resin technology, high-speed curing, and advanced materials Innovation Defense Sector Allnex Resin Technology European Defense Materials Program
Published on 10/26/2026 at 12:00, 4 minutes ago Microbix Presenting at Planet MicroCap Investment Conference
Published on 10/26/2026 at 11:00, 1 hour 4 minutes ago Troubadour Resources Announces Amended Pricing of Previously Announced Non-Brokered Private Placements
Published on 10/24/2026 at 00:04, 2 days 12 hours ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 2 days 12 hours ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/26/2026 at 11:30, 34 minutes ago Original-Research: LAIQON AG (von First Berlin Equity Research GmbH): Buy
Published on 10/26/2026 at 11:20, 44 minutes ago INDUS strengthens its Infrastructure segment with a specialist in concrete solutions
Published on 10/26/2026 at 11:00, 1 hour 4 minutes ago Original-Research: Yggdrasil SPAC 1 AG (to be renamed Innok Robotics Group AG) (von GBC AG): BUY
Published on 10/26/2026 at 11:00, 1 hour 4 minutes ago AL-S Pharma Reports New AP-101 Phase 2 Weight Data and Outlines Phase 3 Clinical Trial in ALS at 2026 NEALS Annual Meeting
Published on 10/26/2026 at 07:30, 4 hours 34 minutes ago EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/23/2026 at 20:33, 2 days 15 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 2 days 18 hours ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/22/2026 at 18:00, 3 days 18 hours ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August